These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11773377)

  • 1. The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.
    Müller B; Patschinsky T; Kräusslich HG
    J Virol; 2002 Feb; 76(3):1015-24. PubMed ID: 11773377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1.
    Hemonnot B; Cartier C; Gay B; Rebuffat S; Bardy M; Devaux C; Boyer V; Briant L
    J Biol Chem; 2004 Jul; 279(31):32426-34. PubMed ID: 15155723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.
    Kudoh A; Takahama S; Sawasaki T; Ode H; Yokoyama M; Okayama A; Ishikawa A; Miyakawa K; Matsunaga S; Kimura H; Sugiura W; Sato H; Hirano H; Ohno S; Yamamoto N; Ryo A
    Retrovirology; 2014 Jan; 11():9. PubMed ID: 24447338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.
    Yu XF; Matsuda Z; Yu QC; Lee TH; Essex M
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3171-9. PubMed ID: 8847526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells.
    Müller B; Tessmer U; Schubert U; Kräusslich HG
    J Virol; 2000 Oct; 74(20):9727-31. PubMed ID: 11000245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles.
    Cartier C; Deckert M; Grangeasse C; Trauger R; Jensen F; Bernard A; Cozzone A; Desgranges C; Boyer V
    J Virol; 1997 Jun; 71(6):4832-7. PubMed ID: 9151881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive mutational analysis reveals p6Gag phosphorylation to be dispensable for HIV-1 morphogenesis and replication.
    Radestock B; Morales I; Rahman SA; Radau S; Glass B; Zahedi RP; Müller B; Kräusslich HG
    J Virol; 2013 Jan; 87(2):724-34. PubMed ID: 23115284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
    Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
    J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect.
    Gottwein E; Jäger S; Habermann A; Kräusslich HG
    J Virol; 2006 Jul; 80(13):6267-75. PubMed ID: 16775314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis.
    Strack B; Calistri A; Göttlinger HG
    J Virol; 2002 Jun; 76(11):5472-9. PubMed ID: 11991975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.
    Martins AN; Waheed AA; Ablan SD; Huang W; Newton A; Petropoulos CJ; Brindeiro RD; Freed EO
    J Virol; 2016 Jan; 90(2):768-79. PubMed ID: 26512081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.
    Bukrinskaya AG; Ghorpade A; Heinzinger NK; Smithgall TE; Lewis RE; Stevenson M
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):367-71. PubMed ID: 8552640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly.
    Votteler J; Neumann L; Hahn S; Hahn F; Rauch P; Schmidt K; Studtrucker N; Solbak SM; Fossen T; Henklein P; Ott DE; Holland G; Bannert N; Schubert U
    Retrovirology; 2011 Feb; 8():11. PubMed ID: 21324168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.
    Schwartz MD; Geraghty RJ; Panganiban AT
    Virology; 1996 Oct; 224(1):302-9. PubMed ID: 8862425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.
    Gurer C; Berthoux L; Luban J
    J Virol; 2005 Jan; 79(2):910-7. PubMed ID: 15613319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of host cell MAPK/ERK-2 incorporation into lentivirus particles: characterization of the interaction between MAPK/ERK-2 and proline-rich-domain containing capsid region of structural protein Gag.
    Gupta P; Singhal PK; Rajendrakumar P; Padwad Y; Tendulkar AV; Kalyanaraman VS; Schmidt RE; Srinivasan A; Mahalingam S
    J Mol Biol; 2011 Jul; 410(4):681-97. PubMed ID: 21762808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination of HIV-1 and MuLV Gag.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Schubert U
    Virology; 2000 Dec; 278(1):111-21. PubMed ID: 11112487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein.
    Sharma A; Bruns K; Röder R; Henklein P; Votteler J; Wray V; Schubert U
    BMC Struct Biol; 2009 Dec; 9():74. PubMed ID: 20015412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.